Therapeutic potential of phosphodiesterase type 5 inhibitors in heart failure with preserved ejection fraction and combined post- and pre-capillary pulmonary hypertension - Kramer, T; Dumitrescu, D; Gerhardt, F (Int J Cardiol, 2019)
et al.